Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study).
BMJ Open
; 11(6): e052312, 2021 06 28.
Article
in En
| MEDLINE
| ID: mdl-34183351
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Depressive Disorder, Major
/
Ketamine
Type of study:
Observational_studies
Aspects:
Ethics
/
Patient_preference
Limits:
Adult
/
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
BMJ Open
Year:
2021
Document type:
Article
Affiliation country:
Australia
Country of publication:
United kingdom